Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Rodent models of PCOS show some similar and some different lipid changes compared to humans.

Hormones and neuropeptides affect hair growth, with androgens having opposite effects on beard and scalp hair.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Reducing 3α,5α-THP in the hippocampus increases seizures in female rats.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.